All-cause mortality among breast cancer patients in a screening trial

Support for breast cancer mortality as an end point

L. Tabar, S. W. Duffy, M. F. Yen, J. Warwick, B. Vitak, H. H. Chen, R. A. Smith

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Background: It has recently been suggested that all-cause mortality is a more appropriate end point than disease specific mortality in cancer screening trials, and that disease specific mortality is biased in favour of screening. This suggestion is based partly on supposed inconsistencies between all-cause mortality results and disease specific results in cancer screening trials, and alleged increases in deaths from causes other than breast cancer among breast cancer cases diagnosed among women invited to screening. Methods: We used data from the Swedish Two-County Trial of mammographic screening for breast cancer, in which 77 080 women were randomised to an invitation to screening and 55 985 to no invitation. We estimated relative risks (RRs) (invited v control) of death from breast cancer, death from other causes within the breast cancer cases, and death from all causes within the breast cancer cases. RRs were adjusted for age and took account of the longer follow up of breast cancer cases in the invited group due to lead time. Results: There was a significant 31% reduction in breast cancer mortality in the invited group (RR 0.69, 95% confidence interval (Cl) 0.58-0.80; p

Original languageEnglish
Pages (from-to)159-162
Number of pages4
JournalJournal of Medical Screening
Volume9
Issue number4
DOIs
Publication statusPublished - 2002
Externally publishedYes

Fingerprint

Breast Neoplasms
Mortality
Cause of Death
Early Detection of Cancer
Confidence Intervals

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

All-cause mortality among breast cancer patients in a screening trial : Support for breast cancer mortality as an end point. / Tabar, L.; Duffy, S. W.; Yen, M. F.; Warwick, J.; Vitak, B.; Chen, H. H.; Smith, R. A.

In: Journal of Medical Screening, Vol. 9, No. 4, 2002, p. 159-162.

Research output: Contribution to journalArticle

Tabar, L. ; Duffy, S. W. ; Yen, M. F. ; Warwick, J. ; Vitak, B. ; Chen, H. H. ; Smith, R. A. / All-cause mortality among breast cancer patients in a screening trial : Support for breast cancer mortality as an end point. In: Journal of Medical Screening. 2002 ; Vol. 9, No. 4. pp. 159-162.
@article{2aa82c2bc765432197669552ac0bec84,
title = "All-cause mortality among breast cancer patients in a screening trial: Support for breast cancer mortality as an end point",
abstract = "Background: It has recently been suggested that all-cause mortality is a more appropriate end point than disease specific mortality in cancer screening trials, and that disease specific mortality is biased in favour of screening. This suggestion is based partly on supposed inconsistencies between all-cause mortality results and disease specific results in cancer screening trials, and alleged increases in deaths from causes other than breast cancer among breast cancer cases diagnosed among women invited to screening. Methods: We used data from the Swedish Two-County Trial of mammographic screening for breast cancer, in which 77 080 women were randomised to an invitation to screening and 55 985 to no invitation. We estimated relative risks (RRs) (invited v control) of death from breast cancer, death from other causes within the breast cancer cases, and death from all causes within the breast cancer cases. RRs were adjusted for age and took account of the longer follow up of breast cancer cases in the invited group due to lead time. Results: There was a significant 31{\%} reduction in breast cancer mortality in the invited group (RR 0.69, 95{\%} confidence interval (Cl) 0.58-0.80; p",
author = "L. Tabar and Duffy, {S. W.} and Yen, {M. F.} and J. Warwick and B. Vitak and Chen, {H. H.} and Smith, {R. A.}",
year = "2002",
doi = "10.1136/jms.9.4.159",
language = "English",
volume = "9",
pages = "159--162",
journal = "Journal of Medical Screening",
issn = "0969-1413",
publisher = "SAGE Publications Ltd",
number = "4",

}

TY - JOUR

T1 - All-cause mortality among breast cancer patients in a screening trial

T2 - Support for breast cancer mortality as an end point

AU - Tabar, L.

AU - Duffy, S. W.

AU - Yen, M. F.

AU - Warwick, J.

AU - Vitak, B.

AU - Chen, H. H.

AU - Smith, R. A.

PY - 2002

Y1 - 2002

N2 - Background: It has recently been suggested that all-cause mortality is a more appropriate end point than disease specific mortality in cancer screening trials, and that disease specific mortality is biased in favour of screening. This suggestion is based partly on supposed inconsistencies between all-cause mortality results and disease specific results in cancer screening trials, and alleged increases in deaths from causes other than breast cancer among breast cancer cases diagnosed among women invited to screening. Methods: We used data from the Swedish Two-County Trial of mammographic screening for breast cancer, in which 77 080 women were randomised to an invitation to screening and 55 985 to no invitation. We estimated relative risks (RRs) (invited v control) of death from breast cancer, death from other causes within the breast cancer cases, and death from all causes within the breast cancer cases. RRs were adjusted for age and took account of the longer follow up of breast cancer cases in the invited group due to lead time. Results: There was a significant 31% reduction in breast cancer mortality in the invited group (RR 0.69, 95% confidence interval (Cl) 0.58-0.80; p

AB - Background: It has recently been suggested that all-cause mortality is a more appropriate end point than disease specific mortality in cancer screening trials, and that disease specific mortality is biased in favour of screening. This suggestion is based partly on supposed inconsistencies between all-cause mortality results and disease specific results in cancer screening trials, and alleged increases in deaths from causes other than breast cancer among breast cancer cases diagnosed among women invited to screening. Methods: We used data from the Swedish Two-County Trial of mammographic screening for breast cancer, in which 77 080 women were randomised to an invitation to screening and 55 985 to no invitation. We estimated relative risks (RRs) (invited v control) of death from breast cancer, death from other causes within the breast cancer cases, and death from all causes within the breast cancer cases. RRs were adjusted for age and took account of the longer follow up of breast cancer cases in the invited group due to lead time. Results: There was a significant 31% reduction in breast cancer mortality in the invited group (RR 0.69, 95% confidence interval (Cl) 0.58-0.80; p

UR - http://www.scopus.com/inward/record.url?scp=12244254445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12244254445&partnerID=8YFLogxK

U2 - 10.1136/jms.9.4.159

DO - 10.1136/jms.9.4.159

M3 - Article

VL - 9

SP - 159

EP - 162

JO - Journal of Medical Screening

JF - Journal of Medical Screening

SN - 0969-1413

IS - 4

ER -